Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

European EGPA Study Group, Giacomo Emmi*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Web of Science)
Original languageEnglish
Pages (from-to)295-306
Number of pages12
JournalArthritis & Rheumatology
Volume74
Issue number2
Early online date30 Dec 2021
DOIs
Publication statusPublished - Feb 2022

Keywords

  • FOLLOW-UP
  • PLACEBO
  • EGPA
  • SAFETY

Cite this